Pharmalot By Ed Silverman Pharmalittle: Pfizer paid its CEO how much? Glaxo says Brexit will not be cheap
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Drug stocks hurt by fears that price hikes are abating
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK
Pharmalot By Ed Silverman UK pharma trade group on Brexit: ‘There’s a potentially negative story here’
Biotech By Meghana Keshavan and Rebecca Robbins Post-Brexit, will the European Medicines Agency be homeless?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Will Brexit force European drug regulators to leave London?